Pyramax is a medicine that contains the active substances pyronaridine tetraphosphate and artesunate. It is available as tablets (180 mg/60 mg) and as granules (60 mg/20 mg in each sachet). Pyramax is used to treat uncomplicated malaria, caused by two types of malaria parasites, *Plasmodium falciparum* and *Plasmodium vivax.* ‘Uncomplicated’ means the disease does not involve severe, life\-threatening symptoms. Pyramax tablets are used for adults and children weighing 20 kg or more and the granules are used for babies and children weighing between 5 and 20 kg. The medicine can only be obtained with a prescription.
Therapeutic Indication
### Publication details Date of opinion 16/02/2012
Therapeutic Area (MeSH)
ATC Code
P01BF06
ATC Item
N/A
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| artesunate | N/A | artesunate |
| pyronaridine | N/A | pyronaridine |
EMA Name
Pyramax - opinion on medicine for use outside EU
Medicine Name
Pyramax
Aliases
N/ANo risk management plan link.